Individualized medicine can complement the principles of population health to deliver better results for patients, according to Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Individualized medicine can complement the principles of population health to deliver better results for patients, according to Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Transcript (slightly modified)
Can personalized medicine and the principles of population health be reconciled with one another, or are they at odds?
So here we are in the middle of a revolution in healthcare, moving from volume-based healthcare—how much care do we give?—to value-based care. No one’s waking up one morning and stepping right into value and leaving volume behind. So we really are moving from volume to volume plus value. And as we live in this volume plus value healthcare world, how do we reconcile the concepts of population health and dynamics disease state health and dynamics registries about accumulating data on the population we treat? And then, diving underneath that and saying, well, we have to reconcile that population analysis of the data with each individual person’s uniqueness and what do we do for that person within that population.
So are the two polar opposites or are they complementary? That’s the question. My belief is, and I think the data shows, that they complement each other. Because if we want to get the best Triple Aim results for patients, best outcomes, best experience in the care process, as they get those and we do it for lower cost in the population, deliver value. If we want to do that, it starts with, what does the science say around how patients need to be diagnosed and treated around a certain condition for instance. But also, what does the precision medicine initiative tell us about how we improve that population scorecard by getting great at what each individual unique patient needs for their own set of drivers, their own set of reasons why their body might need a different medication, or a different dose in a medication. Or of course also, approaching and doing something about their social dynamic and their social determinants.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More